PMS2 alterations were present in 10 patients overall, most commonly in the STS cohort (n=6), including two patients with leiomyosarcoma, two patients with sarcoma NOS, and one patient each with myxofibrosarcoma and pleomorphic liposarcoma. Here, PMS2 is linked to leiomyosarcoma.